In VivoDifferentiation of Mast Cells From Acute Myeloid Leukemia Blasts Carrying a Novel Activating Ligand-Independent C-Kit Mutation

Blood Cells, Molecules, and Diseases - United States
doi 10.1006/bcmd.1998.0191
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Antiangiogenic Protein Kinase Inhibitors SU5416 and SU6668 Inhibit the SCF Receptor (C-Kit) in a Human Myeloid Leukemia Cell Line and in Acute Myeloid Leukemia Blasts

Blood
BiochemistryImmunologyCell BiologyHematology
2001English

Identification and Characterization of an Activating TrkA Deletion Mutation in Acute Myeloid Leukemia

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2000English

Chronic Myelogenous Leukemia With Acquired C-Kit Activating Mutation and Transient Bone Marrow Mastocytosis

The Hematology Journal
2004English

Novel Agents in Acute Myeloid Leukemia

International Journal of Hematology
Hematology
2012English

FLT3-TKD Mutation in Childhood Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2003English

In Situ RHAMM Protein Expression in Acute Myeloid Leukemia Blasts Suggests Poor Overall Survival

Annals of Hematology
MedicineHematology
2011English

Mast-Cell Leukemia Exome Sequencing Reveals a Mutation in the IgE Mast-Cell Receptor Β Chain and KIT V654A

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Bispecific Antibody Releasing-Mesenchymal Stromal Cell Machinery for Retargeting T Cells Towards Acute Myeloid Leukemia Blasts

Blood Cancer Journal
OncologyHematology
2015English

Differential Signaling of Flt3 Activating Mutations in Acute Myeloid Leukemia: A Working Model

Protein & Cell
BiochemistryBiotechnologyDrug DiscoveryCell BiologyMedicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy